APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 12 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Interleukin 12 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025173 pages

Choose your research edition.

Industry ResearchInterleukin 12 Receptor Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 12 Receptor Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Interleukin 12 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 12 Receptor Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 12 Receptor Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Interleukin 12 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Interleukin 12 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Interleukin 12 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Interleukin 12 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Interleukin 12 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Interleukin 12 Receptor include Merck KGaA, Eli Lilly and Company, Neumedicines Inc and Mallinckrodt Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Interleukin 12 Receptor market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Interleukin 12 Receptor and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Interleukin 12 Receptor revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Interleukin 12 Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Interleukin 12 Receptor Segment by Company

Merck KGaA

Eli Lilly and Company

Neumedicines Inc

Mallinckrodt Plc

Interleukin 12 Receptor Segment by Type

LY-3232094

M-9241

NMIL-121

Edodekin Alfa SR

Others

Interleukin 12 Receptor Segment by Application

In-Patient

Out-Patient

Interleukin 12 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 12 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 12 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 12 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Interleukin 12 Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Interleukin 12 Receptor industry.

Chapter 3: Detailed analysis of Interleukin 12 Receptor companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interleukin 12 Receptorrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Interleukin 12 Receptor Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of LY-3232094 Table 3. Key Players of M-9241 Table 4. Key Players of NMIL-121 Table 3. Key Players of Edodekin Alfa SR Table 4. Key Players of Others Table 5. Global Interleukin 12 Receptor Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of In-Patient Table 7. Key Players of Out-Patient Table 8. Global Interleukin 12 Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Interleukin 12 Receptor Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Interleukin 12 Receptor Market Share by Region (2021-2026) Table 11. Global Interleukin 12 Receptor Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Interleukin 12 Receptor Market Share by Region (2027-2032) Table 13. Interleukin 12 Receptor Industry Trends Table 14. Interleukin 12 Receptor Industry Drivers Table 15. Interleukin 12 Receptor Industry Opportunities and Challenges Table 16. Interleukin 12 Receptor Industry Restraints Table 17. Global Interleukin 12 Receptor Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Interleukin 12 Receptor Revenue Market Share by Company (2021-2026) Table 19. Global Interleukin 12 Receptor Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Interleukin 12 Receptor Key Company Head Office and Area Served Table 21. Global Interleukin 12 Receptor Company, Product Type & Application Table 22. Global Interleukin 12 Receptor Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Interleukin 12 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Interleukin 12 Receptor Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Interleukin 12 Receptor Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Interleukin 12 Receptor Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Interleukin 12 Receptor Revenue Market Share by Type (2021-2026) Table 29. Global Interleukin 12 Receptor Revenue Market Share by Type (2027-2032) Table 30. Global Interleukin 12 Receptor Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Interleukin 12 Receptor Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Interleukin 12 Receptor Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Interleukin 12 Receptor Revenue Market Share by Application (2021-2026) Table 34. Global Interleukin 12 Receptor Revenue Market Share by Application (2027-2032) Table 35. Merck KGaA Company Information Table 36. Merck KGaA Business Overview Table 37. Merck KGaA Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Merck KGaA Interleukin 12 Receptor Product Portfolio Table 39. Merck KGaA Recent Development Table 40. Eli Lilly and Company Company Information Table 41. Eli Lilly and Company Business Overview Table 42. Eli Lilly and Company Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Eli Lilly and Company Interleukin 12 Receptor Product Portfolio Table 44. Eli Lilly and Company Recent Development Table 45. Neumedicines Inc Company Information Table 46. Neumedicines Inc Business Overview Table 47. Neumedicines Inc Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Neumedicines Inc Interleukin 12 Receptor Product Portfolio Table 49. Neumedicines Inc Recent Development Table 50. Mallinckrodt Plc Company Information Table 51. Mallinckrodt Plc Business Overview Table 52. Mallinckrodt Plc Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Mallinckrodt Plc Interleukin 12 Receptor Product Portfolio Table 54. Mallinckrodt Plc Recent Development Table 55. North America Interleukin 12 Receptor Market Size by Type (2021-2026) & (US$ Million) Table 56. North America Interleukin 12 Receptor Market Size by Type (2027-2032) & (US$ Million) Table 57. North America Interleukin 12 Receptor Market Size by Application (2021-2026) & (US$ Million) Table 58. North America Interleukin 12 Receptor Market Size by Application (2027-2032) & (US$ Million) Table 59. North America Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 60. North America Interleukin 12 Receptor Market Size by Country (2021-2026) Table 61. North America Interleukin 12 Receptor Market Size by Country (2027-2032) Table 62. Europe Interleukin 12 Receptor Market Size by Type (2021-2026) & (US$ Million) Table 63. Europe Interleukin 12 Receptor Market Size by Type (2027-2032) & (US$ Million) Table 64. Europe Interleukin 12 Receptor Market Size by Application (2021-2026) & (US$ Million) Table 65. Europe Interleukin 12 Receptor Market Size by Application (2027-2032) & (US$ Million) Table 66. Europe Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. Europe Interleukin 12 Receptor Market Size by Country (2021-2026) Table 68. Europe Interleukin 12 Receptor Market Size by Country (2027-2032) Table 69. China Interleukin 12 Receptor Market Size by Type (2021-2026) & (US$ Million) Table 70. China Interleukin 12 Receptor Market Size by Type (2027-2032) & (US$ Million) Table 71. China Interleukin 12 Receptor Market Size by Application (2021-2026) & (US$ Million) Table 72. China Interleukin 12 Receptor Market Size by Application (2027-2032) & (US$ Million) Table 73. Asia Interleukin 12 Receptor Market Size by Type (2021-2026) & (US$ Million) Table 74. Asia Interleukin 12 Receptor Market Size by Type (2027-2032) & (US$ Million) Table 75. Asia Interleukin 12 Receptor Market Size by Application (2021-2026) & (US$ Million) Table 76. Asia Interleukin 12 Receptor Market Size by Application (2027-2032) & (US$ Million) Table 77. Asia Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Asia Interleukin 12 Receptor Market Size by Country (2021-2026) Table 79. Asia Interleukin 12 Receptor Market Size by Country (2027-2032) Table 80. South America, Middle East & Africa Interleukin 12 Receptor Market Size by Type (2021-2026) & (US$ Million) Table 81. South America, Middle East & Africa Interleukin 12 Receptor Market Size by Type (2027-2032) & (US$ Million) Table 82. South America, Middle East & Africa Interleukin 12 Receptor Market Size by Application (2021-2026) & (US$ Million) Table 83. South America, Middle East & Africa Interleukin 12 Receptor Market Size by Application (2027-2032) & (US$ Million) Table 84. South America, Middle East & Africa Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. South America, Middle East & Africa Interleukin 12 Receptor Market Size by Country (2021-2026) Table 86. South America, Middle East & Africa Interleukin 12 Receptor Market Size by Country (2027-2032) Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Interleukin 12 Receptor Product Image Figure 2. Global Interleukin 12 Receptor Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Interleukin 12 Receptor Market Share by Type: 2025 VS 2032 Figure 4. LY-3232094 Image Figure 5. M-9241 Image Figure 6. NMIL-121 Image Figure 7. Edodekin Alfa SR Image Figure 8. Others Image Figure 9. Global Interleukin 12 Receptor Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Interleukin 12 Receptor Market Share by Application: 2025 VS 2032 Figure 11. In-Patient Image Figure 12. Out-Patient Image Figure 13. Global Interleukin 12 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 15. Global Interleukin 12 Receptor Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Interleukin 12 Receptor Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Interleukin 12 Receptor Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Interleukin 12 Receptor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Interleukin 12 Receptor Revenue Market Share by Type (2021-2032) Figure 22. Global Interleukin 12 Receptor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Interleukin 12 Receptor Revenue Market Share by Application (2021-2032) Figure 24. North America Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 25. North America Interleukin 12 Receptor Market Share by Type (2021-2032) Figure 26. North America Interleukin 12 Receptor Market Share by Application (2021-2032) Figure 27. North America Interleukin 12 Receptor Market Share by Country (2021-2032) Figure 28. United States Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 29. Canada Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 31. Europe Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 32. Europe Interleukin 12 Receptor Market Share by Type (2021-2032) Figure 33. Europe Interleukin 12 Receptor Market Share by Application (2021-2032) Figure 34. Europe Interleukin 12 Receptor Market Share by Country (2021-2032) Figure 35. Germany Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 36. France Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 38. Italy Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 39. Russia Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 41. China Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 42. China Interleukin 12 Receptor Market Share by Type (2021-2032) Figure 43. China Interleukin 12 Receptor Market Share by Application (2021-2032) Figure 44. Asia Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 45. Asia Interleukin 12 Receptor Market Share by Type (2021-2032) Figure 46. Asia Interleukin 12 Receptor Market Share by Application (2021-2032) Figure 47. Asia Interleukin 12 Receptor Market Share by Country (2021-2032) Figure 48. Japan Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 52. India Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 53. Australia Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Interleukin 12 Receptor Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Interleukin 12 Receptor Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Interleukin 12 Receptor Market Share by Country (2021-2032) Figure 58. Brazil Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 63. UAE Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 65. Chile Interleukin 12 Receptor Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • LY-3232094
  • M-9241
  • NMIL-121
  • Edodekin Alfa SR
  • Others
Applications
  • In-Patient
  • Out-Patient
Companies covered
  • Merck KGaA
  • Eli Lilly and Company
  • Neumedicines Inc
  • Mallinckrodt Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Interleukin 12 Receptor Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 LY-3232094
  5. 1.2.3 M-9241
  6. 1.2.4 NMIL-121
  7. 1.2.5 Edodekin Alfa SR
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Interleukin 12 Receptor Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 In-Patient
  12. 1.3.3 Out-Patient
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Interleukin 12 Receptor Growth Trends by Region
  15. 1.5.1 Global Interleukin 12 Receptor Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Interleukin 12 Receptor Market Size by Region (2021-2026)
  17. 1.5.3 Interleukin 12 Receptor Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Interleukin 12 Receptor Market Dynamics
  1. 2.1 Interleukin 12 Receptor Industry Trends
  2. 2.2 Interleukin 12 Receptor Industry Drivers
  3. 2.3 Interleukin 12 Receptor Industry Opportunities and Challenges
  4. 2.4 Interleukin 12 Receptor Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Interleukin 12 Receptor Revenue by Company (2021-2026)
  2. 3.2 Global Interleukin 12 Receptor Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Interleukin 12 Receptor Key Company Head office and Area Served
  4. 3.4 Global Interleukin 12 Receptor Company, Product Type & Application
  5. 3.5 Global Interleukin 12 Receptor Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Interleukin 12 Receptor Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Interleukin 12 Receptor Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Interleukin 12 Receptor Tier 1, Tier 2, and Tier 3
4 Interleukin 12 Receptor Market by Type
  1. 4.1 Global Interleukin 12 Receptor Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Interleukin 12 Receptor Market Size by Type (2021-2032)
  3. 4.3 Global Interleukin 12 Receptor Market Size Share by Type (2021-2032)
5 Interleukin 12 Receptor Market by Application
  1. 5.1 Global Interleukin 12 Receptor Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Interleukin 12 Receptor Market Size by Application (2021-2032)
  3. 5.3 Global Interleukin 12 Receptor Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck KGaA
  2. 6.1.1 Merck KGaA Company Information
  3. 6.1.2 Merck KGaA Business Overview
  4. 6.1.3 Merck KGaA Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck KGaA Interleukin 12 Receptor Product Portfolio
  6. 6.1.5 Merck KGaA Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly and Company Interleukin 12 Receptor Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 Neumedicines Inc
  14. 6.3.1 Neumedicines Inc Company Information
  15. 6.3.2 Neumedicines Inc Business Overview
  16. 6.3.3 Neumedicines Inc Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Neumedicines Inc Interleukin 12 Receptor Product Portfolio
  18. 6.3.5 Neumedicines Inc Recent Developments
  19. 6.4 Mallinckrodt Plc
  20. 6.4.1 Mallinckrodt Plc Company Information
  21. 6.4.2 Mallinckrodt Plc Business Overview
  22. 6.4.3 Mallinckrodt Plc Interleukin 12 Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mallinckrodt Plc Interleukin 12 Receptor Product Portfolio
  24. 6.4.5 Mallinckrodt Plc Recent Developments
7 North America
  1. 7.1 North America Interleukin 12 Receptor Market Size (2021-2032)
  2. 7.2 North America Interleukin 12 Receptor Market Size by Type
  3. 7.2.1 North America Interleukin 12 Receptor Market Size by Type (2021-2026)
  4. 7.2.2 North America Interleukin 12 Receptor Market Size by Type (2027-2032)
  5. 7.2.3 North America Interleukin 12 Receptor Market Share by Type (2021-2032)
  6. 7.3 North America Interleukin 12 Receptor Market Size by Application
  7. 7.3.1 North America Interleukin 12 Receptor Market Size by Application (2021-2026)
  8. 7.3.2 North America Interleukin 12 Receptor Market Size by Application (2027-2032)
  9. 7.3.3 North America Interleukin 12 Receptor Market Share by Application (2021-2032)
  10. 7.4 North America Interleukin 12 Receptor Market Size by Country
  11. 7.4.1 North America Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Interleukin 12 Receptor Market Size by Country (2021-2026)
  13. 7.4.3 North America Interleukin 12 Receptor Market Size by Country (2027-2032)
  14. 7.4.4 North America Interleukin 12 Receptor Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Interleukin 12 Receptor Market Size (2021-2032)
  2. 8.2 Europe Interleukin 12 Receptor Market Size by Type
  3. 8.2.1 Europe Interleukin 12 Receptor Market Size by Type (2021-2026)
  4. 8.2.2 Europe Interleukin 12 Receptor Market Size by Type (2027-2032)
  5. 8.2.3 Europe Interleukin 12 Receptor Market Share by Type (2021-2032)
  6. 8.3 Europe Interleukin 12 Receptor Market Size by Application
  7. 8.3.1 Europe Interleukin 12 Receptor Market Size by Application (2021-2026)
  8. 8.3.2 Europe Interleukin 12 Receptor Market Size by Application (2027-2032)
  9. 8.3.3 Europe Interleukin 12 Receptor Market Share by Application (2021-2032)
  10. 8.4 Europe Interleukin 12 Receptor Market Size by Country
  11. 8.4.1 Europe Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Interleukin 12 Receptor Market Size by Country (2021-2026)
  13. 8.4.3 Europe Interleukin 12 Receptor Market Size by Country (2027-2032)
  14. 8.4.4 Europe Interleukin 12 Receptor Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Interleukin 12 Receptor Market Size (2021-2032)
  2. 9.2 China Interleukin 12 Receptor Market Size by Type
  3. 9.2.1 China Interleukin 12 Receptor Market Size by Type (2021-2026)
  4. 9.2.2 China Interleukin 12 Receptor Market Size by Type (2027-2032)
  5. 9.2.3 China Interleukin 12 Receptor Market Share by Type (2021-2032)
  6. 9.3 China Interleukin 12 Receptor Market Size by Application
  7. 9.3.1 China Interleukin 12 Receptor Market Size by Application (2021-2026)
  8. 9.3.2 China Interleukin 12 Receptor Market Size by Application (2027-2032)
  9. 9.3.3 China Interleukin 12 Receptor Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Interleukin 12 Receptor Market Size (2021-2032)
  2. 10.2 Asia Interleukin 12 Receptor Market Size by Type
  3. 10.2.1 Asia Interleukin 12 Receptor Market Size by Type (2021-2026)
  4. 10.2.2 Asia Interleukin 12 Receptor Market Size by Type (2027-2032)
  5. 10.2.3 Asia Interleukin 12 Receptor Market Share by Type (2021-2032)
  6. 10.3 Asia Interleukin 12 Receptor Market Size by Application
  7. 10.3.1 Asia Interleukin 12 Receptor Market Size by Application (2021-2026)
  8. 10.3.2 Asia Interleukin 12 Receptor Market Size by Application (2027-2032)
  9. 10.3.3 Asia Interleukin 12 Receptor Market Share by Application (2021-2032)
  10. 10.4 Asia Interleukin 12 Receptor Market Size by Country
  11. 10.4.1 Asia Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Interleukin 12 Receptor Market Size by Country (2021-2026)
  13. 10.4.3 Asia Interleukin 12 Receptor Market Size by Country (2027-2032)
  14. 10.4.4 Asia Interleukin 12 Receptor Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Interleukin 12 Receptor Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Interleukin 12 Receptor Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Interleukin 12 Receptor Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Interleukin 12 Receptor Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Interleukin 12 Receptor Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst